In prostate cancer, KLK3e, an androgen-induced eRNA, scaffolds the androgen receptor (AR)–associated protein complex could modulate chromosomal architecture and enhance AR-dependent KLK3 expression to promote prostate carcinogenesis (Hsieh et al., 2014). This evidence concerns the gene AR and prostate carcinoma.